Prospective assessment of demographic characteristics associated with worse health related quality of life measures following definitive chemoradiation in patients with locally advanced non-small cell lung cancer

Lung cancer is the leading cause of cancer-related death in the United States, with 224,000 cases and 158,000 deaths in 2016 (1). Approximately one-third of patients present with locally advanced non-small cell lung cancer (LA-NSCLC) (2). These patients receive multi-modality therapy which may include chemotherapy, radiation therapy (RT), and surgery